Global Head of Digital Trials in gBDS

Location: Ingelheim, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
Are you looking for a new professional challenge in a global acting company, would you like to utilize your expertise with digital devices and your experience in clinical trials?

This is a unique opportunity for you to use and advance your professional skills in a demanding international field of work by joining an international, growing and highly-motivated team.

Tasks & responsibilities

  • In your new role you lead collaboration with neighboring and enabling functions in the establishment and implementation of the Boehringer Ingelheim Digital Development Strategy for clinical trials and programs cross Therapeutic Areas. You are focusing on statistical, data collection via various sources and analytics aspects.
  • You are holding the key role in establishing overview and knowledge of available digital state of the art tools and approaches, servcies and tools. Furthermore, you serve as a global aggregative point for internal innovation and ideas in the field of use digital health in clinical trials.
  • As Global Head of Digital Trials gBDS (global Biostatistics & Data Sciences) you ensure feedback and assessment of the implemented tools and approaches for improvement and/or decision taking based on pre-defined metrics and lesson learned. You ensure that solutions identified maximize efficiencies.
  • In your range of duty, you consult and support Therapeutic Areas, trial teams in understanding, implementing and continous use of digital health technologies.

Requirements

  • Preferably Master degree in life/data sciences, information technology, and/or clinical development related majors or equivalent qualification
  • At least 5 years of relevant job experience
  • Familiarity with digital devices and their utilization in clinical trials and thorough understanding of processes and standards (e.g. Clinical Data Interchange Standards Consortium)
  • Ability to communicate and interact effectively with people internally and externally
  • Ability to strategic and economic thinking
  • Fluency in written and spoken English with excellent presentations skills

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best eHealth talent! For further information, please contact us.

Most Popular Now

Open Call SC1-DTH-12-2020: Use of Real-W…

The number of people with chronic illness is growing and almost half of them have multiple chronic conditions. Patients with complex chronic conditions (CCCs) have chronic multi-morbidities or chronic disease...

China to Take on Leading Role in Medical…

Asia, in particular China, has been advancing significantly on its way to a key role in geopolitics, says correspondent Frank Sieren - and towards spearheading developments in medical technologies. At...

Doctors Give Electronic Health Records a…

The transition to electronic health records (EHRs) was supposed to improve the quality and efficiency of healthcare for doctors and patients alike - but these technologies get an "F" rating...

Artificial Intelligence Algorithm can Le…

Artificial Intelligence can be used to predict molecular wave functions and the electronic properties of molecules. This innovative AI method developed by a team of researchers at the University of...

Preventive Health Care Via App

Demand for apps for preventive health care is growing all the time. Particularly popular are diagnostic assistants that record physiological and fitness data. However, there are data protection concerns with...

Bittium Exhibits its Innovative High-Tec…

Bittium exhibits its innovative products and solutions for cardiology and neurology at Medica 2019, the leading international trade fair for the medical sector, on November 18 - 21 in Dusseldorf...

MEDICA 2019 + COMPAMED 2019 Due to Launc…

18 - 21 November 2019, Düsseldorf, Germany. From Monday until Thursday, the entire medical world and health care sector will once again meet in Düsseldorf. With a record participation of a...

Artificial Intelligence-Based Algorithm …

Traumatic brain injury (TBI) is a significant global cause of mortality and morbidity with an increasing incidence, especially in low-and-middle income countries. The most severe TBIs are treated in intensive...

A Mobile App for Managing Mobile Medical…

Beginning of March 2019, Merci Charity Boutique association based in Bucharest, Romania started testing the "Mobile app for mobile medical units and cabinets", which helps the mobile dental practice to...

#FH2019 - The Leading International Conf…

13 - 15 November 2019, Berlin, Germany. This year the German capital will host again the main conference dedicated to Digital Health: Frontiers Health 2019, which will be held from the...

MEDICA and COMPAMED Hold their Own in a …

18 - 21 November 2019, Düsseldorf, Germany. The demand market for medical technology and medical products is becoming increasingly challenging and discriminating worldwide. Providers are adapting to this on a flexible...

Philips Launches its First Clinical Prod…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the U.S. debut of its new cognitive assessment platform IntelliSpace Cognition. Leveraging the power of artificial intelligence...